Dyne Therapeutics (DYN) Current Assets (2019 - 2026)

Dyne Therapeutics' Current Assets history runs 8 years deep, the most recent figure standing at $1.0 billion for Q1 2026.

• In Q1 2026, Current Assets rose 48.08% year-over-year to $1.0 billion; the TTM figure through Mar 2026 stood at $1.0 billion (up 48.08% YoY), while the FY2025 annual figure was $1.1 billion, up 70.88% from the prior year.
• Current Assets was $1.0 billion for Q1 2026 at Dyne Therapeutics, down from $1.1 billion in the prior quarter.
• In the past five years, Current Assets ranged from a high of $1.1 billion in Q4 2025 to a low of $129.4 million in Q4 2023.
• Historically, Current Assets has averaged $526.1 million across 5 years, with a median of $488.1 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Current Assets slumped 51.29% in 2023, then surged 409.59% in 2024.
• A 5-year view of Current Assets shows it stood at $265.6 million in 2022, then plunged by 51.29% to $129.4 million in 2023, then soared by 409.59% to $659.3 million in 2024, then jumped by 70.88% to $1.1 billion in 2025, then fell by 9.37% to $1.0 billion in 2026.
• The last three Current Assets figures came in at $1.0 billion (Q1 2026), $1.1 billion (Q4 2025), and $806.3 million (Q3 2025), per Business Quant data.